In Vitro Diagnostics (IVD) Asia-Pacific Market

Research Report, 2014 -2020

Published Date:
August - 2015

Report Code:
1564

Report Overview

In vitro diagnostics (IVD) are diagnostic tests practiced in an artificial environment. The
overall revenue of the Asia-Pacific IVD market accounted for about $10.7 billion in
2014, and is estimated to reach $15.3 billion by 2020, registering a CAGR of 6.5% over
the forecast period. Considerable increase in the number of chronic and infectious
diseases, growing awareness towards healthcare solutions and technological
advancements in healthcare industry largely supplement the growth of this market.
However, stringent regulatory policies and reimbursements issues in few countries
limit the growth of this market. The rising demand for technologically advanced
diagnostic devices, rise in GDP and per capita income and rise in disposable incomes
facilitate a huge potential for the IVD market in the Asia-Pacific region.

The Asia-Pacific IVD market is segmented based on technique, product type, usability,
application, end user and country. Based on technique, the market is segmented into
immunoassays, clinical chemistry, point-of-care, molecular diagnostics, hematology,
coagulation, microbiology and other clinical techniques. Point-of-care is the highest
revenue-generating segment in the overall IVD techniques market. However, the
molecular diagnostics is the fastest growing technique in the overall IVD techniques
market due to its ability to accurately detect the primary cause of the disease.
Based on product type, the market is segmented into instruments, reagents, data
management systems and services. Instruments segment holds the highest market
share in the Asia-Pacific IVD market followed by rapidly growing reagents segment.
Reagents are largely used in various equipment and play a key role in the overall
diagnosis process. The usability segment is classified as disposable and reusable IVD
devices. Doctors and clinicians largely prefer disposable devices to avoid infections;
generating larger revenue in comparison to reusable devices. The application segment
is categorized into infectious diseases diabetes, cancer/oncology, cardiology,
autoimmune diseases, nephrology, drug testing, HIV/AIDS and others. Infectious
diseases was the highest revenue-generating segment in 2014 and would continue to
maintain its position throughout 2020, due to the rise in incidences of infectious
diseases.

Hospitals and laboratories, academics, point-of-care testing and others form the end
users segment in the Asia-Pacific IVD market. Hospitals and laboratories generate the
highest revenue, followed by point-of-care. A significant rise in the number of hospitals
and laboratories across the Asia-Pacific region along with increased awareness about
developments in healthcare largely contribute to the growth of this segment.

Based on country, the Asia-Pacific IVD market is segmented into India, China, Japan,
Australia, South Korea and rest of the Asia-Pacific. Currently, China leads the AsiaPacific IVD market, owing to the high demand for testing in outpatient clinics, huge
population base and rising medical insurance services by the Chinese government.
However, Australia and South Korea hold the significant market share due to the wellsupported reimbursement facilities and well-regulated IVD devices, which comes
under the regulation of medical devices.
Key companies profiled in this market include Danaher Corporation, Roche
Diagnostics, Abbott Laboratories, Siemens Healthcare, Alere Inc., Affymetrix Inc.,
Becton, Dickinson and Company, Bio-Rad Laboratories, BioMerieux, Vela Diagnostics
and others. Product launch and technological advancements are the few strategies
adopted by the key players of IVD market. The companies are currently focusing on
innovative technologies such as automated and point-of-care IVD devices.

Get more details on IVD at: http://www.apacmarket.com/topmarket/apac-in-vitro-diagnostics-market

KEY BENEFITS:

Extensive coverage of the Asia-Pacific IVD market including drivers, restraints

and opportunities would help professionals to better understand the market
behaviour
The projections in the report are made by analyzing the current market trends
and market potential for the period of 20142020
A comprehensive analysis of the market scenario in terms of technologies,
applications, usability, product type end users and geography helps identify the
growth opportunities in the Asia-Pacific IVD market
The market attractiveness analysis for the Asia-Pacific IVD market provides
strategic assistance to the decision makers
Key market players within the Asia-Pacific IVD market are profiled in the report
and their strategies are analysed thoroughly, which helps in understanding
competitive outlook of this market

KEY MARKET SEGMENTS:

Asia-Pacific IVD market is segmented into applications, technology, product type,
usability, end user, and geography.

Asia-Pacific IVD Market By Techniques

Immunoassays
Clinical Chemistry
Point Of Care
Microbiology
Molecular Diagnostics
Whole Blood Glucose
Hematology
Coagulation
Other clinical techniques

The Asia-Pacific IVD Market By Product Type

Instruments
Reagents
Data management systems
Services

The Asia-Pacific IVD Market By Usability

Disposable Devices
Reusable Devices

The Asia-Pacific IVD Market By Applications

Infectious Diseases
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Diseases
Nephrology
Drug Testing
HIV/AIDS
Others

The Asia-Pacific IVD Market By End-User

Hospitals and Laboratories

Academics
Point of Care Testing
Others

The Asia-Pacific IVD Market By Countries

China
India
Japan
Australia
South Korea
Others

Table of Contents
Chapter 1
Chapter 2
Chapter 3
Chapter 4
Chapter 5
Chapter 6
Chapter 7
Chapter 8
Chapter 9
Chapter 10

Introduction
Executive Summary
Market Overview
Asia Pacific IVD Market, by Techniques
Asia Pacific IVD Market, by Product Type
Asia Pacific IVD Market, by Usability
Asia Pacific IVD Market, by Application
Asia Pacific IVD Market, by End-users
Asia Pacific IVD Market, by Countries
Company Profiles

CONTACT US:
Syed Ali
Level 32, 101 Miller Street,
North Sydney, NSW 2060
Toll Free: +61-280 454 214
Landline: +91 (20) 60604041 (India)
Email: help@apacmarket.com
Web - http://www.apacmarket.com